Sort
51,570 grants matching “autoimmune disease”
Elucidating the Role of Regulatory T cells in Establishing and Maintaining a Th2 Niche in Skin
$682,917Michael David Rosenblum · University Of California, San Francisco · R01 · FY2024 · AR
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
$682,876Tracy M Handel · University Of California, San Diego · R01 · FY2022 · AI
Immune Mechanisms in Ocular Graft versus Host Disease
$682,870Victor L Perez · University Of Miami School Of Medicine · R01 · FY2016 · EY
The pregnancy transcriptome in rheumatoid arthritis
$682,761Damini Jawaheer · Children'S Hospital & Res Ctr At Oakland · R01 · FY2018 · AR
Immunogenetic determinants of cancer risk
$682,727Robert M Samstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies
$682,709Ronald J Falk · Univ Of North Carolina Chapel Hill · R01 · FY2023 · DK
CAR-T cell treatment of CNS Autoimmunity
$682,626Gregory Wu · Washington University · R01 · FY2024 · AI
Precision mapping of regulatory causal variants by expression CROPseq
$682,624Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2024 · HG
Kallikrein-PAR interactions in skin inflammation
$682,599Nicole Leanne Ward · Case Western Reserve University · R01 · FY2019 · AR
Integrative approaches to understand systemic lupus erythematosus etiology in trans-ancestry genetic studies
$682,586Dajiang Liu · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · AI
Project 1: Transgenic TCR-mediated tumor therapy
$682,429Philip D Greenberg · University Of Washington · P01 · FY2021 · CA
Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells
$682,418Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Control of Autoimmunity by Regulatory T Cells
$682,418Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Biomarkers of Parkinson Disease and Related Disorders
$682,371David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Autoimmunity Center of Excellence - Rochester
$682,356Ignacio E. Sanz · University Of Rochester · U19 · FY2010 · AI
Precision mapping of regulatory causal variants by expression CROPseq
$682,310Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2025 · HG
Engineered probiotic for the treatment of autoimmune diseases
$682,280Christine Beeton · Baylor College Of Medicine · R01 · FY2023 · AI
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
$682,270Wendell A Lim · University Of California, San Francisco · R01 · FY2015 · CA
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
$682,247Meghan E. Sise · Massachusetts General Hospital · R01 · FY2024 · DK
Targeted therapy in Type 1 diabetes
$682,232Anna Moore · Massachusetts General Hospital · R24 · FY2013 · DK
The role of TCR, ligand, and signal strength in human γδ T cell development
$682,218Maria Ciofani · Research Inst Of Fox Chase Can Ctr · P01 · FY2025 · AI
Rituximab Therapy in Patients with IPF
$682,198Steven R Duncan · University Of Alabama At Birmingham · R01 · FY2017 · HL
Oklahoma Autoimmunity Center of Excellence
$682,136Judith A James · Oklahoma Medical Research Foundation · U19 · FY2012 · AI
Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases
$682,102Stephen I Katz · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets
$681,914Timothy J Durfee · Dnastar, Inc. · R44 · FY2024 · GM